| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2007 | CA2574723A1 Coated surgical needles |
| 07/24/2007 | USRE39743 Antibiotics, bactericides |
| 07/24/2007 | US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport |
| 07/24/2007 | US7247746 Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 07/24/2007 | US7247734 In which the 3-phenyl group is 2,4-dihydroxy-substituted, e.g., 4-[5-bromo-4-(4-methoxy-phenyl)-1H-pyrazol-3-yl]-6-chloro-benzene-1,3-diol; heat shock protein 90 inhibitors |
| 07/24/2007 | US7247730 dexmethylphenidate hydrochloride, with high optical purity, which excludes the use of expensive resolving agents; novel intermediates |
| 07/24/2007 | US7247728 Bicyclic N-arylamides |
| 07/24/2007 | US7247725 Gamma-aminoamide modulators of chemokine receptor activity |
| 07/24/2007 | US7247717 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/24/2007 | US7247716 Recombinant sequence, its preparation and use |
| 07/24/2007 | US7247655 Such as methyl-5-aminolevulinate hydrochloride; porphyrins; antitumor agents; anticancer agents |
| 07/24/2007 | US7247654 E.g., N-(2-benzylamino-4-carbamimidoyl-benzyl)-3,5-dimethoxy-4-methyl-benzamide; these compounds inhibit, for example, thrombin, factor Xa, factor XIa, factor IXa, and especially factor VIIa. |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247652 β-benzyloxyaspartate derivatives with amino group on benzene ring |
| 07/24/2007 | US7247651 2,7-substituted indoles |
| 07/24/2007 | US7247650 Macrolides and methods for producing same |
| 07/24/2007 | US7247649 e.g 1-[4-(4-{2-[2-(E)-(4-Chloro-2-fluoro-phenyl)-vinyl]-oxazol-4-ylmethoxy}-phenyl)-butyl]-1H-[1,2,3]triazole; inhibitors of the HER (human epidermal growth factor receptors)-signalling pathway; antiprolirative; cancer |
| 07/24/2007 | US7247648 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 07/24/2007 | US7247646 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 07/24/2007 | US7247645 Dihydropyridine derivatives |
| 07/24/2007 | US7247644 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics |
| 07/24/2007 | US7247643 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 07/24/2007 | US7247642 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| 07/24/2007 | US7247641 Compounds, derivatives, compositions, preparation and uses |
| 07/24/2007 | US7247640 Comprises as an active ingredient a sulphostin-related compound such as 3(S)-amino-1-((S)-amino(sulfoamino)-phosphinyl)-2-piperidone |
| 07/24/2007 | US7247639 Xanthines 1-substituted with an alkyl group, 3-substituted with a phenylalkylene group and 8-substituted with an arylalkylene group, e.g. 3-[2-[4-(5-aminopentyl-3-amidocarboxypropanoyl)]aminophenyl]ethyl]-8-benzyl-7-[2-ethyl(2-hydroxyethyl)amino]ethyl-1-propylxanthine |
| 07/24/2007 | US7247638 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives. |
| 07/24/2007 | US7247637 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life |
| 07/24/2007 | US7247636 Phenolic guanidine sodium channel blockers |
| 07/24/2007 | US7247635 Pyrazole derivative |
| 07/24/2007 | US7247634 Rifamycin derivatives effective against drug-resistant microbes |
| 07/24/2007 | US7247633 Pyrimidine compounds and their use |
| 07/24/2007 | US7247632 for treatment of microbial infections; potent inhibitors of (bMAP) bacterial aminopeptidase |
| 07/24/2007 | US7247631 Chemokine receptors (CCR5); for lowering HIV-RNA plasma levels |
| 07/24/2007 | US7247630 Nitrogen compounds such as 3-(5-hydroxyhexyl)-1-methyl-1H-imidazo(2,1-f)purine-2,4(3H,6H)-dione, used for prophylaxis of diseases associated with cytokine intracellular signal transduction |
| 07/24/2007 | US7247629 Antitumoral analogs of et-743 |
| 07/24/2007 | US7247628 Cannabinoid receptor ligands and uses thereof |
| 07/24/2007 | US7247627 non-hygroscopic, crystalline anhydrous maleate salt of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene) methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 07/24/2007 | US7247626 prophylaxis and treatment of herpes viral infections; e.g. N-Cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(4-fluorophenyl)pyrazolo[1,5-c]pyrimidin-7-amine |
| 07/24/2007 | US7247625 treatment of uterine fibroids, endometriosis, dysmenorrhea, breast cancer, uterine caner, ovarian cancer, prostate cancer, and meningioma; hormone replacement therapy, including perimenopausal, menopausal, and post-menopausal hormone replacement therapy; and in the treatment of skin disorders |
| 07/24/2007 | US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer |
| 07/24/2007 | US7247623 Method of treating dry eye disease with non-drying antihistamines |
| 07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
| 07/24/2007 | US7247621 Antiviral phosphonate compounds and methods therefor |
| 07/24/2007 | US7247620 preventive therapy using nucleic acid coding a protein |
| 07/24/2007 | US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling |
| 07/24/2007 | US7247617 Oxacyclohexadecadienone macrolide oxime antibiotics substituted with a mycaminosyl group; increased antibacterial activities over the tilmicosins |
| 07/24/2007 | US7247616 Pyrazole derivatives and diabetic medicine containing them |
| 07/24/2007 | US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents |
| 07/24/2007 | US7247610 Suppression tumor growth |
| 07/24/2007 | US7247502 Nicotine hapten that is nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization |
| 07/24/2007 | US7247444 Use of interleukin-19 to treat cervical cancer |
| 07/24/2007 | US7247328 Chromium (III) alpha amino acid complexes |
| 07/24/2007 | US7247319 Conditioning the quantity of microparticles so that a flowability index of the quantity is greater than about 60 |
| 07/24/2007 | US7247318 Sustained release; therapy for attention deficit disorders |
| 07/24/2007 | US7247317 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) |
| 07/24/2007 | US7247316 Compositions and methods for treating lymphoma |
| 07/24/2007 | US7247315 Compositions and medical device for transdermal delivery of a drug and methods of making and using same |
| 07/24/2007 | US7247313 Polyacrylates coatings for implantable medical devices |
| 07/24/2007 | US7247301 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 07/24/2007 | US7247295 Use of 1,2-decandiol for combating germs causing body odor |
| 07/24/2007 | US7247294 Skin lightening agents, compositions and methods |
| 07/24/2007 | US7247288 For bone/tooth engineering and repair; bone morphogenic proteins; stents; kits |
| 07/24/2007 | US7246486 Combination of selected opioids with other active substances for use in the therapy of urinary incontinence |
| 07/24/2007 | CA2479846C Phosphonomethoxymethylpurine/pyrimidine derivatives |
| 07/24/2007 | CA2411277C Neurotoxin implant |
| 07/24/2007 | CA2317834C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnf.alpha. levels |
| 07/24/2007 | CA2246429C Erbb3 antibodies |
| 07/24/2007 | CA2242991C Use of antioxidant agents to treat cholestatic liver disease |
| 07/24/2007 | CA2238274C Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids having retinoid-like biological activity |
| 07/24/2007 | CA2234833C Composition comprising a microorganism culture medium and its use |
| 07/24/2007 | CA2230350C Combination preparation for use in dementia |
| 07/24/2007 | CA2192480C Benzopyrans and their use as therapeutic agents |
| 07/24/2007 | CA2188695C Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/24/2007 | CA2117330C The use of psoralen compounds to inhibit restenosis following angioplasty |
| 07/24/2007 | CA2097185C Viral recombinant vectors for expression in muscle cells |
| 07/23/2007 | CA2573472A1 Biodegradable hemostatic compositions |
| 07/19/2007 | WO2007082292A2 Tri-substituted 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 07/19/2007 | WO2007082262A2 Novel compounds |
| 07/19/2007 | WO2007082206A2 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 07/19/2007 | WO2007082178A2 Prostaglandin reductase inhibitors |
| 07/19/2007 | WO2007082079A2 Piperidine amide derivatives as protein kinase inhibitors |
| 07/19/2007 | WO2007082052A2 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases |
| 07/19/2007 | WO2007081995A2 Urotensin ii receptor antagonists |
| 07/19/2007 | WO2007081980A2 Methods and compositions for treating prostate cancer |
| 07/19/2007 | WO2007081978A2 Modulators of hepatocyte growth factor / c-met activity |
| 07/19/2007 | WO2007081974A2 Viral hepatitis treatment |
| 07/19/2007 | WO2007081966A2 Small molecules for treating cancer and abnormal cell proliferation disorders |
| 07/19/2007 | WO2007081909A2 Forms of dolasetron mesylate and processes for their preparation |
| 07/19/2007 | WO2007081907A2 Crystalline forms of dolasetron base and processes for preparation thereof |
| 07/19/2007 | WO2007081901A2 Pyrimidinone derivatives as protein kinase inhibitors |
| 07/19/2007 | WO2007081897A2 Fused triazole tachykinin receptor antagonists |
| 07/19/2007 | WO2007081878A2 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells |
| 07/19/2007 | WO2007081871A1 Therapeutic salt compositions of sulfonyl ester prodrugs of proton pump inhibitors and methods for their preparation |
| 07/19/2007 | WO2007081857A2 Cycloalkylamines as monoamine reuptake inhibitors |
| 07/19/2007 | WO2007081808A2 Compounds and derivatives for the treatment of medical conditions by modulating hormone-sensitive lipase activity |
| 07/19/2007 | WO2007081773A2 Treatment of fatty liver |
| 07/19/2007 | WO2007081744A2 Methods and compositions for administration of iron |
| 07/19/2007 | WO2007081736A1 Osmotic dosage form with controlled release and fast release aspects |